# Paricalcitol for the Treatment of Immunoglobulin A Nephropathy

> **NCT00599963** · PHASE3 · WITHDRAWN · sponsor: **Chinese University of Hong Kong**

## Conditions studied

- IgA Nephropathy

## Interventions

- **DRUG:** paricalcitol

## Key facts

- **NCT ID:** NCT00599963
- **Lead sponsor:** Chinese University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2008-01
- **Primary completion:** 2009-10
- **Final completion:** 2009-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Funding problem.
- **Last updated:** 2015-08-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00599963

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00599963, "Paricalcitol for the Treatment of Immunoglobulin A Nephropathy". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00599963. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*